Januvia
Product Images NDC 58118-0277

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 58118-0277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstruc (963792a9 4029 4e7b 9759 9ad52e1b0962 01)

Chemstruc (963792a9 4029 4e7b 9759 9ad52e1b0962 01)
Chemical structure of the active ingredient in JANUVIA, showing a complex molecule with fluorinated aromatic rings and a trifluoromethyl-substituted heterocyclic ring, along with phosphate and water molecules represented separately.*
FDA Label Image

Fig1 (963792a9 4029 4e7b 9759 9ad52e1b0962 02)

Fig1 (963792a9 4029 4e7b 9759 9ad52e1b0962 02)
A line graph comparing the least squares mean change from baseline over 24 weeks for different treatments: placebo, Metformin 1000 mg twice daily, Sitagliptin 50 mg once daily, Metformin 500 mg twice daily, Sitagliptin 50 mg twice daily plus Metformin 500 mg twice daily, and Sitagliptin 50 mg twice daily plus Metformin 1000 mg twice daily. The x-axis represents weeks, and the y-axis represents the LS mean change from baseline.*
FDA Label Image

Fig2 (963792a9 4029 4e7b 9759 9ad52e1b0962 03)

Fig2 (963792a9 4029 4e7b 9759 9ad52e1b0962 03)
A line graph comparing the LS mean change from baseline over 52 weeks between Januvia 100 mg and Glipizide. The x-axis represents time in weeks, while the y-axis shows the LS mean change from baseline, ranging from 0 to -1.5. Both treatments show a decrease initially, with similar trends throughout the study period.*
FDA Label Image

Jan100lab3 (963792a9 4029 4e7b 9759 9ad52e1b0962 04)

Jan100lab3 (963792a9 4029 4e7b 9759 9ad52e1b0962 04)
JANUVIA 100 mg tablets label distributed by Clinical Solutions Wholesale. The label indicates a package size of 30 tablets with RX only. It includes the product NDC 58118-0277-3, lot number 123Iotnum, and fill date 03/15/15. Manufacturer is MSD Canada Inc. Additional barcode and QR code are present on the label.*
FDA Label Image

Jan100lab6 (963792a9 4029 4e7b 9759 9ad52e1b0962 05)

Jan100lab6 (963792a9 4029 4e7b 9759 9ad52e1b0962 05)
Label for JANUVIA Tablets 100 mg by Clinical Solutions Wholesale. The package contains 60 tablets. The label includes the NDC number 58118-0277-6, a barcode, a QR code, prescription-only notice, lot number, fill date, and manufacturer NDC.*
FDA Label Image

Jan100lab9 (963792a9 4029 4e7b 9759 9ad52e1b0962 06)

Jan100lab9 (963792a9 4029 4e7b 9759 9ad52e1b0962 06)
Label for Januvia Tablets 100 mg by Clinical Solutions Wholesale, NDC 58118-0277-9. The label indicates a bottle of 90 tablets, prescription use only. It includes a lot number, fill date, manufacturer NDC, and manufacturer name (MSD Care, Inc). Barcode and QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.